Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

FDA grants fast track status to Biomira's breast cancer vaccine

May 10, 2000

Maxamine plus IL-2 improves survival in late-stage malignant melanoma

May 4, 2000

Neurocrine Biosciences obtains orphan drug status for glioblastoma therapy

May 2, 2000

Neurocrine Biosciences reports positive results from phase I/II malignant glioma trial

April 27, 2000

Campath MAA accepted for review by European authorities

April 26, 2000

Novelos Therapeutics initiates first U.S. trial of BAM-002

April 25, 2000

Coley initiates phase I/II trials of CpG-7909 for cancer

April 24, 2000

Preclinical results for Avax's AC Vaccine technology in breast cancer presented at AACR

April 14, 2000

SuperGen and AVI BioPharma establish marketing agreement for Avicine

April 11, 2000

Zadaxin plus chemotherapy shows promise in malignant melanoma

April 11, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.